AMEX

AIM ImmunoTech Inc. (AIM)

♥ 709 Thanks from members

Live price chart, market sentiment, and community perspectives for AIM ImmunoTech Inc. (AMEX: AIM).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: AIM ImmunoTech ScientistsLeadership: Thomas K. Equels (CEO)Holder: Institutional InvestorsHolder: Retail ShareholdersAmpligen (rintatolimod)Immuno-pharma therapeutics#AIM stock#AIM ImmunoTech#Ampligen#biotech penny stock#AMEX AIM